Compare MCK & CL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | CL |
|---|---|---|
| Founded | 1833 | 1806 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 63.6B |
| IPO Year | N/A | N/A |
| Metric | MCK | CL |
|---|---|---|
| Price | $814.96 | $78.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $882.69 | $90.40 |
| AVG Volume (30 Days) | 848.8K | ★ 6.0M |
| Earning Date | 11-05-2025 | 01-30-2026 |
| Dividend Yield | 0.40% | ★ 2.65% |
| EPS Growth | ★ 66.19 | 2.56 |
| EPS | ★ 32.12 | 3.57 |
| Revenue | ★ $387,094,000,000.00 | $20,097,000,000.00 |
| Revenue This Year | $14.87 | $3.88 |
| Revenue Next Year | $8.32 | $3.37 |
| P/E Ratio | $25.34 | ★ $21.94 |
| Revenue Growth | ★ 17.23 | N/A |
| 52 Week Low | $558.13 | $74.55 |
| 52 Week High | $895.58 | $100.18 |
| Indicator | MCK | CL |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 49.88 |
| Support Level | $793.92 | $76.02 |
| Resistance Level | $818.92 | $78.50 |
| Average True Range (ATR) | 17.31 | 1.30 |
| MACD | -6.82 | -0.15 |
| Stochastic Oscillator | 21.63 | 45.08 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.